CD95/Fas stoichiometry in future precision medicine

被引:0
|
作者
Sica, Mauricio [1 ]
Roussel, Murielle [2 ,3 ]
Legembre, Patrick [2 ]
机构
[1] Inst Balseiro UNCuyo, Bariloche Atom Ctr, CONICET, Dept Fis Med GAANS CNEA, Ave Bustillo 9500, San Carlos De Bariloche, Rio Negro, Argentina
[2] Univ Limoges, UMR CNRS 7276, INSERM U1262, CRIBL, 2 Rue Marcland, Limoges, France
[3] CHU Dupuytren, Clin Hematol & Cellular Therapy Dept, Limoges, France
关键词
OSTEOCLAST DIFFERENTIATION FACTOR; FAS LIGAND; SIGNALING PATHWAY; DECOY RECEPTOR; DEATH DOMAIN; TNF; COMPLEX; CELLS; OSTEOPROTEGERIN; IDENTIFICATION;
D O I
10.1038/s41418-025-01493-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD95, also known as Fas, belongs to the tumor necrosis factor (TNF) receptor superfamily. The main biological function of this receptor is to orchestrate and control the immune response since mutations in CD95 or deregulation of its downstream signaling pathways lead to auto-immunity and inflammation. Interestingly, more than twenty years ago, pioneer studies highlighted that like TNFR1, TRAILR1 or CD40, CD95 pre-associates at the plasma membrane in a ligand-independent fashion. This self-association occurs through a domain designated pre-ligand assembly domain or PLAD. Although the disruption of this pre-association prevents CD95 signaling, no drugs targeting this region have been generated because many questions remain on the stoichiometry and conformation of this receptor. Despite more than 40.000 publications, no crystal structure of CD95 alone or in combination with its ligand, CD95L, exists. Based on other TNFR members, we herein discuss the predicted conformation of CD95 at the plasma membrane and how these putative structures might account for the induction of the cell signaling pathways.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Functional expression of CD95/fas antigen and Bcl-2 on cord blood hematopoietic progenitor cells
    Ma Yanping
    Zou Ping
    Current Medical Science, 2002, 22 (1) : 24 - 27
  • [42] Role of metalloproteases in the CD95 signaling pathways
    Devel, Laurent
    Guedeney, Nicolas
    Bregant, Sarah
    Chowdhury, Animesh
    Jean, Mickael
    Legembre, Patrick
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [43] Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes
    Lowin, B
    Mattman, C
    Hahne, M
    Tschopp, J
    INTERNATIONAL IMMUNOLOGY, 1996, 8 (01) : 57 - 63
  • [44] Altered protein expression levels of Fas/CD95 and Fas Ligand in differentially vulnerable brain areas in rats after global cerebral ischemia
    Padosch, SA
    Popp, E
    Vogel, P
    Böttiger, BW
    NEUROSCIENCE LETTERS, 2003, 338 (03) : 247 - 251
  • [45] Fas/Apo-1 (CD95)-mediated apoptosis of neutrophils with Fas ligand (CD95L)-expressing tumors is crucial for induction of inflammation by neutrophilic polymorphonuclear leukocytes associated with antitumor immunity
    Shimizu, M
    Fontana, A
    Takeda, Y
    Yoshimoto, T
    Tsubura, A
    Matsuzawa, A
    CELLULAR IMMUNOLOGY, 2001, 207 (01) : 41 - 48
  • [46] CD95, BIM and T cell homeostasis
    Bouillet, Philippe
    O'Reilly, Lorraine A.
    NATURE REVIEWS IMMUNOLOGY, 2009, 9 (07) : 514 - 519
  • [47] Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients
    Mohammadzadeh, Adel
    Pourfathollah, Ali Akbar
    Tahoori, Mohammad Taher
    Daneshmandi, Saeed
    Langroudi, Ladan
    Akhlaghi, Masoumeh
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (09) : 2833 - 2836
  • [48] The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
    Qadir, Abdul S.
    Stults, Austin M.
    Murmann, Andrea E.
    Peter, Marcus E.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [49] Mutations within the 5′ region of FAS/CD95 gene in nodal diffuse large B-cell lymphoma
    Scholl, Vanesa
    Stefanoff, Claudio Gustavo
    Hassan, Rocio
    Spector, Nelson
    Renault, Ilana Zalcberg
    LEUKEMIA & LYMPHOMA, 2007, 48 (05) : 957 - 963
  • [50] Fas (APO-1/CD95) mRNA is down-regulated in liver regeneration after hepatectomy in rats
    Kiba, T
    Saito, S
    Numata, K
    Sekihara, H
    JOURNAL OF GASTROENTEROLOGY, 2000, 35 (01) : 34 - 38